Ovarian Cancer Clinical Trial

BOLSTER: Building Out Lifelines for Safety, Trust, Empowerment and Renewal

Summary

This research study is evaluating a new intervention, BOLSTER, which was designed to provide more support for patients with gynecologic and gastrointestinal cancers and their caregivers after a hospitalization.

View Full Description

Full Description

Hospitalizations can be difficult for patients with cancer, especially when they are transitioning home. Patients and caregivers are often expected to perform complex medical and nursing tasks with little or no preparation. Patients and caregivers report high levels of unmet needs for information about how best to manage symptoms and new medical procedures (such as managing new tubes, lines or drains).

The study team has developed a research project which aims to address these needs. If a patient agrees to participate in the study, she will take part in a program called BOLSTER (Building Out Lifelines for Safety, Trust, Empowerment and Renewal). BOLSTER will provide patients and caregivers with education and skills training, symptom management, and support across care settings.

View Eligibility Criteria

Eligibility Criteria

Patient inclusion criteria

Adults (≥18 years old);
GYN or GI cancers receiving anti-neoplastic therapy;
Hospitalized, recently hospitalized (i.e. within the first 2 visits after a hospitalization), or recent outpatient placement of tube, line, or drain (e.g. PleurX catheter);
Plan to receive ongoing care at DFCI;
Willingness to be audio taped for the study (for monitoring of study fidelity).
Have complex care needs (e.g. an ostomy, ileostomy, a gastric tube, percutaneous nephrostomy tubes, a PleurX catheter, or need for total parenteral nutrition)

Patient exclusion criteria

Unable to read and respond to questions in English;
Cognitive impairment;
Unable to complete the baseline interview;
Plan for immediate hospice referral

Caregiver inclusion criteria

Adults (≥18 years old);
Family member or friend of an eligible patient;
Willingness to be audio taped for the study (for monitoring of study fidelity);
Willingness to participate in study visits

Caregiver exclusion criteria:

Unable to read and respond to questions in English,
Cognitive impairment
Unable to complete the baseline interview

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

98

Study ID:

NCT03367247

Recruitment Status:

Active, not recruiting

Sponsor:

Dana-Farber Cancer Institute

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Dana Farber Cancer Institute
Boston Massachusetts, 02115, United States

How clear is this clinincal trial information?

Study is for people with:

Ovarian Cancer

Estimated Enrollment:

98

Study ID:

NCT03367247

Recruitment Status:

Active, not recruiting

Sponsor:


Dana-Farber Cancer Institute

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider